Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10562896 6-5 fused rings as C5a inhibitors

Patent 10562896 was granted and assigned to ChemoCentryx on February, 2020 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
ChemoCentryx
ChemoCentryx
0
Date Filed
May 29, 2018
0
Date of Patent
February 18, 2020
0
Patent Applicant
ChemoCentryx
ChemoCentryx
0
Patent Application Number
15991703
0
Patent Citations
‌
US Patent 10035768 C5aR antagonists
Patent Citations Received
‌
US Patent 11384079 6-5 fused rings as C5a inhibitors
‌
US Patent 11479553 5-5 fused rings as C5a inhibitors
‌
US Patent 11485737 Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors
‌
US Patent 11608336 Prodrugs of fused-bicyclic C5aR antagonists
0
‌
US Patent 11773091 6-5 fused rings as C5a inhibitors
‌
US Patent 11478460 Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
Patent Inventor Names
Yibin Zeng
0
Christopher W. Lange
0
Hiroko Tanaka
0
Penglie Zhang
0
Pingchen Fan
0
Rajinder Singh
0
Rebecca M. Lui
0
Sreenivas Punna
0
Venkat Reddy Mali
0
Viengkham Malathong
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10562896
0
Patent Primary Examiner
‌
D Margaret M Seaman
0

Find more entities like US Patent 10562896 6-5 fused rings as C5a inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo